Wells Fargo & Company Neogenomics Inc Transaction History

Wells Fargo & Company

  • $433 Billion
  • Q4 2024

A detailed history of Wells Fargo & Company transactions in Neogenomics Inc stock. As of the latest transaction made, Wells Fargo & Company holds 84,391 shares of NEO stock, worth $828,719. This represents 0.0% of its overall portfolio holdings.

Number of Shares
84,391
Previous 78,336 7.73%
Holding current value
$828,719
Previous $1.16 Million 20.35%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$13.0 - $18.43 $78,715 - $111,593
6,055 Added 7.73%
84,391 $1.39 Million
Q3 2024

Nov 13, 2024
BUY
$13.4 - $17.73 $20,703 - $27,392
1,545 Added 2.01%
78,336 $1.16 Million
Q2 2024

Aug 13, 2024
BUY
$13.01 - $15.77 $40,500 - $49,092
3,113 Added 4.23%
76,791 $1.07 Million
Q1 2024

May 10, 2024
BUY
$14.06 - $16.79 $228,053 - $272,333
16,220 Added 28.23%
73,678 $1.16 Million
Q4 2023

Feb 09, 2024
SELL
$11.67 - $20.73 $118,660 - $210,782
-10,168 Reduced 15.04%
57,458 $929,000
Q3 2023

Nov 13, 2023
SELL
$12.15 - $17.85 $55,950 - $82,199
-4,605 Reduced 6.38%
67,626 $831,000
Q2 2023

Aug 15, 2023
BUY
$14.1 - $19.83 $399,735 - $562,180
28,350 Added 64.61%
72,231 $1.16 Million
Q1 2023

May 12, 2023
BUY
$9.09 - $19.45 $227,013 - $485,744
24,974 Added 132.09%
43,881 $763,000
Q4 2022

Feb 13, 2023
SELL
$6.45 - $12.07 $22,607 - $42,305
-3,505 Reduced 15.64%
18,907 $174,000
Q3 2022

Nov 14, 2022
SELL
$7.86 - $12.91 $90,924 - $149,342
-11,568 Reduced 34.04%
22,412 $193,000
Q2 2022

Aug 12, 2022
SELL
$7.06 - $13.97 $479,345 - $948,507
-67,896 Reduced 66.65%
33,980 $277,000
Q1 2022

May 16, 2022
SELL
$12.15 - $35.28 $1.6 Million - $4.66 Million
-131,995 Reduced 56.44%
101,876 $1.24 Million
Q4 2021

Feb 14, 2022
SELL
$30.49 - $48.49 $17.9 Million - $28.5 Million
-587,983 Reduced 71.54%
233,871 $7.98 Million
Q3 2021

Nov 15, 2021
BUY
$41.66 - $52.52 $1.53 Million - $1.92 Million
36,615 Added 4.66%
821,854 $39.6 Million
Q2 2021

Aug 16, 2021
SELL
$36.62 - $51.69 $3.06 Million - $4.32 Million
-83,568 Reduced 9.62%
785,239 $35.5 Million
Q1 2021

May 13, 2021
SELL
$41.56 - $59.88 $2.88 Million - $4.14 Million
-69,193 Reduced 7.38%
868,807 $41.9 Million
Q4 2020

Feb 09, 2021
SELL
$36.08 - $56.47 $686,602 - $1.07 Million
-19,030 Reduced 1.99%
938,000 $50.5 Million
Q3 2020

Nov 05, 2020
BUY
$33.26 - $40.48 $1.99 Million - $2.43 Million
59,960 Added 6.68%
957,030 $35.3 Million
Q2 2020

Aug 13, 2020
SELL
$24.21 - $31.02 $1.74 Million - $2.22 Million
-71,697 Reduced 7.4%
897,070 $27.8 Million
Q1 2020

May 14, 2020
BUY
$20.5 - $34.53 $19.9 Million - $33.5 Million
968,767 New
968,767 $26.7 Million

Others Institutions Holding NEO

# of Institutions
282
Shares Held
124M
Call Options Held
751K
Put Options Held
107K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.24B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email